The effectiveness and safety of Chuna manual therapy adjuvant to Western medicine in patients with chronic obstructive pulmonary disease: study protocol for a randomized, single-blind, investigator-initiated, pilot trial

Kyung Hee University Oriental Medical Center0 个研究点目标入组 40 人开始时间: 待定最近更新: 2021年8月30日

试验速览

暂无简介。

•1) Patients aged between 40 – 80 years
•2) Patients who satisfy the COPD clinical diagnostic criteria (FEV1/FVC<0.70 [GOLD] on the Spirometry) and receiving the standard drug therapy
•3) Patients who voluntarily signs and submits the written consent for participation in the present clinical study

•1) Individuals with comorbidity of severe respiratory disease other than COPD (cystic fibrosis, pneumonia, ILD, lung cancer, etc.)
•2) Individuals with a history of alcohol or other substance abuse or dependency
•3) Individuals showing a clinically significant disease or disorder of the liver, kidneys, cardiovascular system, respiratory system, endocrine system, and central nervous system, based on the results of the physicochemical test and clinical examination, and those with a history of malignant tumor or mental disorder (Here, individuals without 5-year postoperative recurrence are allowed to participate)
•4) Individuals showing a change of drug use within the past three months prior to the present study
•5) Individuals who are unable to walk independently
•6) Individuals who have received kinetic, physical, or manual therapy related to respiratory rehabilitation within the past month
•7) Individuals who are currently receiving an oxygen therapy
•8) Individuals with symptoms that prevent the use of CT
•9) Individuals who are pregnant or planning a pregnancy
•10) Individuals who are deemed unsuitable for the clinical study by the principal investigator

发起方

Kyung Hee University Oriental Medical Center